FairScope Lab
EN 繁中 简中

AMGN

Valuation Healthcare · Drug Manufacturers - General Data as of 2026-03-31

P/E Ratio · Metrics

P/E Ratio

26.31

PEG Ratio

0.72

Dividend Yield

-

Gross Margin

68.16%

Net Margin

21.11%

Revenue CAGR 3Y

12.18%

ROE

79.17%

ROA

7.87%

Buyback Yield

-0.18%

Current Ratio

1.26

Magic Earn Yield

-

Altman Z-Score

-

Fair Value River

Score

Valuation 62
Profitability 60
Growth 41
Health 42
Yield 0
← Back to Dashboard